-
15m 1sPart 3 | Session 10 The SAFE-PAD Study: Dr Eric Secemsky
-
11m 45sPart 3 | Session 11 Findings From the HOST-EXAM Trial: Dr Hyo-Soo Kim
-
15m 16sPart 3 | Session 12 Findings from the RAFT-AF Trial: Dr Anthony Tang
-
33m 28s
-
16m 3sPart 2 | Session 1 The Coalition ACTION Trial: Dr Harriette Van Spall & Dr Renato Lopes
-
16m 20sPart 2 | Session 2 The RADIANCE-HTN TRIO Trial: Dr Harriette Van Spall & Dr Ajay J Kirtane
-
15m 2sPart 2 | Session 3 The ISCHEMIA Trial: Dr Harriette Van Spall & Dr Gregg Stone
-
11m 30sPart 2 | Session 4 The LIFE Trial: Dr Harriette Van Spall & Dr Douglas L Mann
-
9m 1sPart 2 | Session 5 The STRENGTH Study: Dr Harriette Van Spall & Dr Steven E Nissen
-
16m 6s
-
11m 22sPart 3 | Session 1 Findings from the WASE COVID Study: Dr Frederico M Asch
-
12m 33sPart 3 | Session 2 The Prague OCHA Study: Dr Jan Belohlavek
-
7m 15sPart 3 | Session 3 The VOYAGER PAD Trial: Dr Rupert Bauersachs
-
8m 58sPart 3 | Session 4 30-day Results of the TRISCEND Study: Dr Susheel Kodali
-
10m 38sPart 3 | Session 5 The HOLIDAY Monitors Trial: Dr Gregory Marcus
-
Part 3 | Session 6 The CONNECT-HF Trial: Dr Adam DeVore
-
15m 45sPart 3 | Session 7 The DARE-19 Randomized Trial: Dr Mikhail Kosiborod
-
10m 39sPart 3 | Session 8 The Tailor-PCI Follow-up Study: Dr Naveen Pereira
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provided a concise analysis of the late-breaking science results.
For a deeper dive into key randomized clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
The ACC. 21 Edition of Masterclass video highlighted the results of the ACC Survey on the hostile work environment.
More from this programme
Part 1
View from the Thoraxcenter: Wrap Up
Part 2
Late-breaker Discussion Series
Part 3
Expert Interviews
Part 4
Masterclass
Faculty Biographies
Paul M Ridker
Senior Physician, Brigham and Women's Hospital Eugene Braunwald Professor of Medicine, Harvard Medical School
Dr Paul M Ridker is director of the Center for Cardiovascular Disease Prevention, a translational research unit at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS).
Dr Ridker received his medical degree from HMS. He then completed an internal medicine residency and a cardiology fellowship at BWH. He has authored over 500 peer-reviewed publications, 150 reviews and book chapters, and five textbooks related to cardiovascular medicine. Dr Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease.